CobasTaqMan (n = 17; b19,814) AUC = 0.98
|
Sensitivity
|
0.78 (0.76–0.80)
|
205.13
|
92.20%
|
< 0.001
|
Specificity
|
0.99 (0.99–0.99)
|
127.21
|
87.40%
|
< 0.001
|
Positive likelihood ratio (PLR)
|
41.59 (27.80–62.18)
|
98.14
|
83.70%
|
< 0.001
|
Negative likelihood ratio (NLR)
|
0.18 (0.13–0.23)
|
134.36
|
88.10%
|
< 0.001
|
Diagnostic odds ratio (DOR)
|
273.14 (181.45–411.17)
|
47.6
|
66.40%
|
< 0.001
|
Light Cycler (n = 7; b1159) AUC = 0.97
|
Sensitivity
|
0.85 (0.80–0.88)
|
61.71
|
90.30%
|
< 0.001
|
Specificity
|
0.99 (0.98–0.99)
|
10.09
|
40.50%
|
0.121
|
Positive likelihood ratio (PLR)
|
21.65 (6.82–68.72)
|
17.45
|
65.60%
|
0.008
|
Negative likelihood ratio (NLR)
|
0.17 (0.08–0.38)
|
63.77
|
90.60%
|
< 0.001
|
Diagnostic odds ratio (DOR)
|
150.52 (31.97–708.78)
|
20.35
|
70.50%
|
< 0.002
|
Cepheid and others (n = 22; b14,839) AUC = 0.99
|
Sensitivity
|
0.78 (0.77–0.80)
|
729.43
|
97.10%
|
< 0.001
|
Specificity
|
0.99 (0.99–0.99)
|
299.13
|
93.00%
|
< 0.001
|
Positive likelihood ratio (PLR)
|
38.50 (19.65–75.42)
|
234.62
|
91.00%
|
< 0.001
|
Negative likelihood ratio (NLR)
|
0.22 (0.15–0.33)
|
594.30
|
96.50%
|
< 0.001
|
Diagnostic odds ratio (DOR)
|
221.44 (94.94–516.51)
|
208.25
|
89.90%
|
< 0.001
|